Company Filing History:
Years Active: 2021
Title: The Innovations of Carl Hurt
Introduction
Carl Hurt is an accomplished inventor based in Stanford, California. He has made significant contributions to the field of biochemistry, particularly in the area of protein interactions. His work focuses on the modulation of calcineurin protein-protein interactions, which has important implications for various medical conditions.
Latest Patents
Carl Hurt holds a patent for "Peptide modulators of specific calcineurin protein-protein interactions." This patent outlines methods for modulating the interaction between calcineurin and a calcineurin-binding protein partner. The methods include contacting a cell with a peptidic agent that influences the interaction between calcineurin and a TRPV channel. Additionally, the patent describes pharmaceutical compositions that contain a peptidic agent selectively modulating this interaction. The patent also provides methods for treating conditions in subjects by targeting the interaction between calcineurin and a calcineurin-binding TRPV channel. Furthermore, it includes screening methods to identify candidate agents that can modulate calcineurin protein-protein interactions. Carl Hurt has 1 patent to his name.
Career Highlights
Carl Hurt is affiliated with Leland Stanford Junior University, where he conducts his research and development. His work has contributed to advancements in understanding protein interactions and their implications in health and disease.
Collaborations
He has collaborated with notable colleagues, including Eric Gross and Daria D Mochly-Rosen, to further his research endeavors.
Conclusion
Carl Hurt's innovative work in peptide modulators and protein interactions showcases his dedication to advancing scientific knowledge and medical applications. His contributions are vital in the ongoing exploration of biochemical interactions and their therapeutic potential.